價(jià)格 | 詢(xún)價(jià) |
包裝 | 1克 |
最小起訂量 | 1克 |
發(fā)貨地 | 上海 |
更新日期 | 2024-11-08 |
英文名稱(chēng):AT-406 (SM-406; Debio-1143) | CAS:1071992-99-8 |
純度規(guī)格: 99%+ | 產(chǎn)品類(lèi)別: 抑制劑 |
生物活性 Xevinapant (AT-406) is a potent and orally bioavailable Smac mimetic and an antagonist of IAPs, and it binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, respectively. IC50 & Target[1] cIAP1 1.9 nM (Ki) cIAP2 5.1 nM (Ki) XIAP 66.4 nM (Ki) 體外研究 Xevinapant mimic closely the AVPI peptide in both hydrogen bonding and hydrophobic interactions with XIAP, with additional hydrophobic contacts with W323 of XIAP. Xevinapant is more sensitive to these IAPs than Smac AVPI peptide with 50-100 fold binding affinities. Xevinapant (1 μM) completely restores the activity of caspase-9, which is suppressed by 500 nM XIAP BIR3 in a cell-free system. In MDA-MB-231 cell, Xevinapant induces rapid cellular cIAP1 degradation and also pulls down the cellular XIAP protein. Xevinapant effectively inhibits lots of human cancer cell lines and shows IC50 of 144 and 142 nM in MDA-MB-231 cell and SK-OV-3 ovarian cell, with low toxicity against normal-like human breast epithelial MCF-12F cells and primary human normal prostate epithelial cells. Xevinapant induces apoptosis in MDA-MB-231 cell by inducing activation of caspase-3 and cleavage of PARP. Xevinapant displays single agent activity in ovarian cancer cell lines. The IC50 values of AT-406 in these ovarian cancer cells range from 0.05-0.5 μg/mL. Xevinapant exhibits anti-ovarian cancer efficacy both as a single agent and in combination with carboplatin. Xevinapant (30 μg/mL) induced degradation of XIAP in the drug sensitive ovarian cancer cell lines.
AT-406 是一種有效的,可口服的 Smac 模擬物,為 IAPs 的拮抗劑,能夠抑制 XIAP,cIAP1 和 cIAP2 蛋白,Ki 值分別為 66.4,1.9 和 5.1 nM。
成立日期 | 2015-11-27 (9年) | 注冊(cè)資本 | 1000000 |
員工人數(shù) | 10-50人 | 年?duì)I業(yè)額 | ¥ 100萬(wàn)-300萬(wàn) |
主營(yíng)行業(yè) | 醫(yī)藥中間體,生物活性小分子,原料藥 | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,定制 |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP3年
|
上海嘉定區(qū)澄瀏公路52號(hào)
|
2024-11-08 | |
¥1599.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2024-10-31 | |
詢(xún)價(jià) |
VIP10年
|
上海升德醫(yī)藥科技有限公司
|
2024-10-29 | |
¥375 |
VIP3年
|
TargetMol中國(guó)(陶術(shù)生物)
|
2024-09-29 | |
¥900 |
南京百鑫德諾生物科技有限公司
|
2024-09-26 | ||
¥1354.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-08-16 | |
詢(xún)價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-04-23 | |
詢(xún)價(jià) |
武漢貝爾卡生物醫(yī)藥有限公司
|
2023-05-30 | ||
詢(xún)價(jià) |
上海銳輝醫(yī)藥科技有限公司
|
2021-11-04 |